Iran Daru (XTEH:IRDR1) Equity-to-Asset : 0.00 (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Iran Daru's Total Stockholders Equity for the quarter that ended in . 20 was IRR0.00 Mil. Iran Daru's Total Assets for the quarter that ended in . 20 was IRR0.00 Mil.

The historical rank and industry rank for Iran Daru's Equity-to-Asset or its related term are showing as below:

XTEH:IRDR1's Equity-to-Asset is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Iran Daru Equity-to-Asset Historical Data

The historical data trend for Iran Daru's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Equity-to-Asset Chart

Iran Daru Annual Data

Trend

Equity-to-Asset

Iran Daru Semi-Annual Data

Equity-to-Asset

Competitive Comparison of Iran Daru's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iran Daru's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Iran Daru's Equity-to-Asset falls into.

Iran Daru Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Iran Daru's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )	=	Total Stockholders Equity	/	Total Assets
	=		/
	=

Iran Daru's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )	=	Total Stockholders Equity	/	Total Assets
	=		/
	=

Iran Daru (XTEH:IRDR1) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Iran Daru Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Iran Daru's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines